This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Prices will rise in...

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

The Industry’s Leading Event in Europe to Accelerate Therapeutics to Market by Expediting R&D, Improving CMC Efficiency, and Building New Partnerships

Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region.

Early Bird Savings: Register by June 28 & Save £1100

Don't miss out on our best pricing! Register for this event by June 28th to lock in our lowest rate, saving you an impressive £1100. After this date, prices will increase. Secure your spot today and enjoy substantial savings.

KEY AREAS OF FOCUS

Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.

The TIDES Europe 2023 hybrid program features scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus below.

Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.

Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics and Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies

Macromolecular Drug Delivery

Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing

TIDES Europe 2024 by the Numbers

100+

Attendees

0+

Speakers

0+

Exhibitors

0

Immersive Workshops

0

Content-Driven Tracks

Big Waves at TIDES Europe 2023

TIDES Europe 2023 featured 100+ Sessions from 100+ leaders in oligonucleotides, peptides, mRNA, genome editing and more! With 600+ attendees, thank you for making 2023 the biggest TIDES Europe event yet. See you next year in Hamburg!

CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. 

To begin building your custom sponsorship package today, contact:

Companies #, A-F: Jennifer Wickett, JWickett@informaconnectls.com

Companies G-Z: Michael Moriarty, MMoriarty@informaconnectls.com